— Gilgamesh's lead asset, bretisilocin (GM-2505), is a potential best-in-class psychedelic compound currently in Phase 2 development for the treatment of major depressive disorder (MDD). — Bretisilocin is a novel, short-acting serotonin (5-HT)2A receptor agonist and 5-HT releaser. AbbVie (NYSE: ABBV) and Gilgamesh Pharmaceuticals Inc. (“Gilgamesh”) today announced a definitive agreement under which AbbVie will […]

Xi'an in northwest China, where the ancient Silk Road began, now symbolizes China's fusion of heritage and innovation. Part of our “Into Tech Park” series, this edition explores how technology fuels inclusive growth through the eyes of international students and entrepreneurs. Initiatives like the China-Europe Railway Express and Qinchuangyuan platform highlight Xi'an's role as a

— Delivers Training and Coaching-Focused Conversations with Athletes, Leaders, and Influencers — First Episode Features Vanderbilt Head Football Coach Clark Lea on August 27 — Expands D1's Reach while Reinforcing its Authority in Athletic Training and Franchise Growth D1 Training, a leading fitness and enrichment concept that utilizes the five core tenets of athletic-based training

Today, the Prime Minister, Mark Carney, met with the President of Poland,Karol Nawrocki, in Warsaw, Poland. The Prime Minister and the President discussed the strong relationship between Canada and Poland, enriched by the nearly one million Canadians of Polish heritage. Prime Minister Carney and President Nawrocki discussed their countries' efforts to deepen trade, defence, and

Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that Ian Woo, President and Chief Financial Officer will be participating in person at investor conferences in New York City. Morgan Stanley 23rd Annual Global Healthcare Conference Date: Monday September

In Collaboration with the Vestibular Disorders Association (VeDA), FYZICAL Celebrates National Balance Awareness Week This fall, FYZICAL Therapy & Balance Centers, a leading national physical therapy brand, is calling on communities nationwide to combat falls among older adults in recognition of National Falls Prevention Awareness Month and National Balance Awareness Week starting on September 14

EmVenio Clinical Research expands global trial access with brand consolidation and launches Patient Navigator™ to improve access for trial participants. PCM Trials, along with its subsidiaries EmVenio Research and Clinical Trial Service, are aligning under a single name – EmVenio Clinical Research. This consolidation brings together each company's unique strengths under one entity to offer

(OtherOTC:KSEZ),(OTC US:KSEZ),(NASDAQ:SAGT), SCHAUMBURG, Ill. and KUALA LUMPUR, Malaysia, Aug. 25, 2025 (GLOBE NEWSWIRE) — Kinetic Seas Incorporated (OTCQB: KSEZ) and SagteÑ Global Limited (NASDAQ: SAGT) today announced the signing of a multi-year agreement to deploy a private white-labeled version of the SKILLIKS AI platform, hosted in the United States. SKILLIKS is the first AI development

(NASDAQ:SAGT),(Other OTC:KSEZ), KUALA LUMPUR, MALAYSIA, Aug. 25, 2025 (GLOBE NEWSWIRE) — Sagtec Global (NASDAQ: SAGT), a leading innovator in Point-of-Sale (POS) systems, today announced a strategic licensing agreement with Kinetic Seas Incorporated (OTCQB: KSEZ). Through the agreement, Sagtec will integrate Kinetic Seas' AI platform, Skilliks, into its portfolio, creating a powerful foundation to scale AI-powered

(SWX:WIHN),(NASDAQ:WKEY), WISeKey Unveils Its Next-Generation WISeID: A Fully Decentralized Identity Platform for People and Objects Geneva, Switzerland – August 25, 2025 – WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a global leader in cybersecurity, blockchain, and IoT, today announced the convergence of WISeID, its people identity platform, and SEALCOIN, its object identity platform,